Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 236 | 7 | 19 | -492 | 0 |
| Gross Profit | 236 | 7 | 19 | -121 | N/A |
| Operating Expenses | 2,486 | 2,330 | 2,532 | 1,052 | 4,291 |
| Operating Income | -2,250 | -2,323 | -2,513 | -1,544 | -4,291 |
| Interest Expense | 1,338 | 2,972 | 1,578 | 424 | 0 |
| Other Income | 1,968 | -4,816 | -9,652 | 7 | 8 |
| Pre-tax Income | -1,621 | -10,110 | -13,743 | -1,961 | -4,283 |
| Net Income Continuous | -1,621 | -10,110 | -13,743 | -1,961 | -4,283 |
| Net Income Discontinuous | 96 | -1,033 | -994 | -3,117 | -1,869 |
| Net Income Extraordinary | 6,409 | N/A | N/A | N/A | N/A |
| Net Income | $4,883 | $-11,143 | $-14,737 | $-5,078 | $-6,152 |
| EPS Basic Total Ops | 2.00 | -4.80 | -6.20 | -2.20 | -2.60 |
| EPS Basic Continuous Ops | -0.60 | -4.40 | -5.80 | -0.49 | -1.80 |
| EPS Basic Discontinuous Ops | 0.00 | -0.40 | -0.40 | -1.60 | -0.80 |
| EPS Diluted Total Ops | 2.00 | -4.80 | -6.20 | -2.20 | -2.60 |
| EPS Diluted Continuous Ops | -0.60 | -4.40 | -5.80 | -0.49 | -1.80 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.40 | -0.40 | -1.60 | -0.80 |
| EBITDA(a) | $-1,024 | $557 | $-824 | $-761 | $-3,726 |